Evidence map›Paper›PMID 32810442›Full record

ArticleDevelopmental cell2020

Metabolic Regulation of Inflammasome Activity Controls Embryonic Hematopoietic Stem and Progenitor Cell Production.

Jenna M Frame, Caroline Kubaczka, Timothy L Long, Virginie Esain, Rebecca A Soto, Mariam Hachimi, Ran Jing, Arkadi Shwartz, Wolfram Goessling, George Q Daley and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Efficient Generation of Functional TCRαβbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Gpr171 regulates embryonic hematopoietic stem cell emergence via ERK1/2 and Notch signaling.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Ace2 safeguards embryonic hematopoietic stem and progenitor cell production by restraining Nlrp3-mediated pyroptosis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Inflammation in Development and Aging: Insights from the Zebrafish Model.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Jenna M FrameStem Cell Program, Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.
Caroline KubaczkaStem Cell Program, Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.
Timothy L LongStem Cell Program, Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.
Virginie EsainStem Cell Program, Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.
Rebecca A SotoStem Cell Program, Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA; Developmental and Regenerative Biology Program, Harvard Medical School, Boston, MA 02115, USA.
Mariam HachimiStem Cell Program, Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.
Ran JingStem Cell Program, Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.
Arkadi ShwartzGenetics Division, Brigham & Women's Hospital, Boston, MA 02115, USA.
Wolfram GoesslingDevelopmental and Regenerative Biology Program, Harvard Medical School, Boston, MA 02115, USA; Genetics Division, Brigham & Women's Hospital, Boston, MA 02115, USA; Gastroenterology Division, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.
George Q DaleyStem Cell Program, Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA; Developmental and Regenerative Biology Program, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Trista E NorthStem Cell Program, Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA; Developmental and Regenerative Biology Program, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA. Electronic address: trista.north@childrens.harvard.edu.
Boston Children's Hospital · USBrigham and Women's Hospital · USHarvard Stem Cell Institute · USHarvard University · US

Funding

Customized stem cells for clinical application in blood disordersR24DK092760 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI COLLINS, JAMES J, DALEY, GEORGE Q · 2011 to 2018
$10.7M
Stem cells for therapeutics discovery in genetic blood disordersU01HL134812 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI DALEY, GEORGE Q, LIPTON, JEFFREY M · 2016 to 2022
$8.3M
Molecular Circuits in the Hematopoietic Stem Cell NicheRC2DK120535 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI COLLINS, JAMES J, DALEY, GEORGE Q · 2020 to 2024
$8.2M
Training Program in Angiogenesis &InflammationT32HL007893 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI DVORAK, HAROLD FISHER · 1998 to 2017
$5.5M
Biomechanical Activation of Yap Induces Hematopoietic Stem Cell ProductionR01HL152636 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI NORTH, TRISTA E. · 2020 to 2023
$2.2M
Developmental Activation of the Inflammasome Controls Hematopoietic Stem Cell ProductionR01HL154580 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI NORTH, TRISTA E. · 2020 to 2023
$2.2M
Metabolic regulation of hematopoietic stem cell specification and functionR01DK098241 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI NORTH, TRISTA E. · 2014 to 2018
$2.0M
NHLBI NIH HHS R01 HL152636NHLBI NIH HHS R01 HL154580NHLBI NIH HHS T32 HL007893NHLBI NIH HHS U01 HL134812NIDDK NIH HHS R01 DK098241NIDDK NIH HHS R24 DK092760NIDDK NIH HHS RC2 DK120535
6 · The paper itself

Abstract

Embryonic hematopoietic stem and progenitor cells (HSPCs) robustly proliferate while maintaining multilineage potential in vivo; however, an incomplete understanding of spatiotemporal cues governing their generation has impeded robust production from human induced pluripotent stem cells (iPSCs) in vitro. Using the zebrafish model, we demonstrate that NLRP3 inflammasome-mediated interleukin-1-beta (IL1β) signaling drives HSPC production in response to metabolic activity. Genetic induction of active IL1β or pharmacologic inflammasome stimulation increased HSPC number as assessed by in situ hybridization for runx1/cmyb and flow cytometry. Loss of inflammasome components, including il1b, reduced CD41

Indexed as

AnimalsCell DifferentiationCore Binding Factor Alpha 2 SubunitEmbryonic DevelopmentEmbryonic Stem CellsEmbryo, NonmammalianHematopoiesisHematopoietic Stem CellsHumansInduced Pluripotent Stem CellsInflammasomesZebrafishCore Binding Factor Alpha 2 SubunitInflammasomesRUNX1 protein, humanendothelial-to-hematopoietic transition (EHT)hematopoietic stem cell (HSC)IL1βinflammasomeinflammationiPSCNlrp3zebrafish

Identifiers

PMID32810442
PMCPMC8008739
OpenAlexW3073328849

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.